3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Phase 1/2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
164
Neoplasms
130
Prostatic Neoplasms
70
Lung Neoplasms
65
Colorectal Neoplasms
64
Motor Activity
37
Uterine Cervical Neoplasms
32
Pancreatic Neoplasms
31
Brain Neoplasms
28
Head and Neck Neoplasms
25
Ovarian Neoplasms
24
Carcinoma, Non-Small-Cell Lung
24
Carcinoma, Hepatocellular
21
Rectal Neoplasms
20
Disease
18
Depression
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Anxiety Disorders
17
Stomach Neoplasms
16
Glioblastoma
16
Colonic Neoplasms
16
Melanoma
14
Leukemia
13
Hematologic Neoplasms
13
Multiple Myeloma
12
Glioma
12
Carcinoma, Renal Cell
12
Urinary Bladder Neoplasms
11
Papillomavirus Infections
11
Lymphoma, Follicular
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Cirrhosis
×
30 days
×
Clear all
NCT01082419
2026-05-14
NARFI
University Hospital, Bordeaux
Phase NA
Completed
109 enrolled
NCT05786482
2026-05-08
EMPOwer
University of Alberta
Phase NA
Completed
825 enrolled